ArticleOncotarget2017

First-line dose-dense chemotherapy with docetaxel, cisplatin, folinic acid and 5-fluorouracil (DCF) plus panitumumab in patients with locally advanced or metastatic cancer of the stomach or gastroesophageal junction: final results and biomarker analysis from an Italian oncology group for clinical research (GOIRC) phase II study.

Gianluca Tomasello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.